Publication: Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6
| dc.contributor.author | Cabrera-Rodríguez, Romina | |
| dc.contributor.author | Pérez-Yanes, Silvia | |
| dc.contributor.author | Montelongo, Rafaela | |
| dc.contributor.author | Lorenzo-Salazar, José M | |
| dc.contributor.author | Estévez-Herrera, Judith | |
| dc.contributor.author | García-Luis, Jonay | |
| dc.contributor.author | Íñigo-Campos, Antonio | |
| dc.contributor.author | Rubio-Rodríguez, Luis A | |
| dc.contributor.author | Muñoz-Barrera, Adrián | |
| dc.contributor.author | Trujillo-González, Rodrigo | |
| dc.contributor.author | Dorta-Guerra, Roberto | |
| dc.contributor.author | Casado, Concepcion | |
| dc.contributor.author | Pernas, Maria | |
| dc.contributor.author | Blanco, Julià | |
| dc.contributor.author | Flores, Carlos | |
| dc.contributor.author | Valenzuela-Fernández, Agustín | |
| dc.contributor.funder | Red de Investigación Cooperativa en Investigación en Sida (España) | es_ES |
| dc.contributor.funder | Plan Nacional de I+D+i (España) | es_ES |
| dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | es_ES |
| dc.contributor.funder | Government of Catalonia (España) | es_ES |
| dc.contributor.funder | Ministerio de Asuntos Económicos y Transformación Digital (España) | es_ES |
| dc.contributor.funder | Gobierno de Canarias (España) | es_ES |
| dc.contributor.funder | Instituto Tecnológico y de Energías Renovables (España) | es_ES |
| dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | es_ES |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | es_ES |
| dc.contributor.funder | Agencia Canaria de Investigación, Innovación y Sociedad de la Información | es_ES |
| dc.contributor.funder | Unión Europea. Fondo Social Europeo (ESF/FSE) | es_ES |
| dc.contributor.funder | Fundación CajaCanarias | es_ES |
| dc.contributor.funder | Fundación Doctor Manuel Morales | es_ES |
| dc.contributor.funder | Agencia Estatal de Investigación (España) | es_ES |
| dc.date.accessioned | 2022-11-17T13:42:08Z | |
| dc.date.available | 2022-11-17T13:42:08Z | |
| dc.date.issued | 2022-05-31 | |
| dc.description.abstract | The transactive response DNA-binding protein (TARDBP/TDP-43) influences the processing of diverse transcripts, including that of histone deacetylase 6 (HDAC6). Here, we assessed TDP-43 activity in terms of regulating CD4+ T-cell permissivity to HIV-1 infection. We observed that overexpression of wt-TDP-43 increased both mRNA and protein levels of HDAC6, resulting in impaired HIV-1 infection independently of the viral envelope glycoprotein complex (Env) tropism. Consistently, using an HIV-1 Env-mediated cell-to-cell fusion model, the overexpression of TDP-43 levels negatively affected viral Env fusion capacity. Silencing of endogenous TDP-43 significantly decreased HDAC6 levels and increased the fusogenic and infection activities of the HIV-1 Env. Using pseudovirus bearing primary viral Envs from HIV-1 individuals, overexpression of wt-TDP-43 strongly reduced the infection activity of Envs from viremic non-progressors (VNP) and rapid progressors (RP) patients down to the levels of the inefficient HIV-1 Envs observed in long-term non-progressor elite controllers (LTNP-EC). On the contrary, silencing endogenous TDP-43 significantly favored the infectivity of primary Envs from VNP and RP individuals, and notably increased the infection of those from LTNP-EC. Taken together, our results indicate that TDP-43 shapes cell permissivity to HIV-1 infection, affecting viral Env fusion and infection capacities by altering the HDAC6 levels and associated tubulin-deacetylase anti-HIV-1 activity. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work is supported by the Spanish AIDS network “Red Temática Cooperativa de Investigación en SIDA” RD12/0017/0002, RD12/0017/0028, RD12/0017/0034, RD16/0025/0011, RDCIII16/0002/0005 and RD16/0025/0041 as part of the Plan Nacional R + D+I and co-funded by the Spanish “Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER)”. J.B. is a researcher from “Fundació Institut de Recerca en Ciències de la Salut Germans Trias i Pujol” supported by the Health Department of the Catalonian Government/Generalitat de Catalunya and ISCIII grant numbers PI17/01318 and PI20/00093 (to J.B.). Work in CC Lab was supported by grants SAF (2010-17226) and (2016-77894-R) from MINECO (Spain), FIS (PI 13/02269, ISCIII) and PI20/00093. Work in CF Lab was supported by the Cabildo Insular de Tenerife (grants CGIEU0000219140 and “Apuestas científicas del ITER para colaborar en la lucha contra la COVID-19”); the agreement with the Instituto Tecnológico y de Energías Renovables (ITER) to strengthen scientific and technological education, training research, development and innovation in Genomics, Personalized Medicine and Biotechnology (grant number OA17/008). A.V.-F.’s Lab is supported by the European Regional Development Fund (ERDF), RTI2018-093747-B-100 (“Ministerio de Ciencia e Innovación”, Spain), “Ministerio de Ciencia, Innovación y Universidades” (Spain), ProID2020010093 (“Agencia Canaria de Investigación, Innovación y Sociedad de la Información” and European Social Fund), UNLL10-3E-783 (ERDF and “Fundación CajaCanarias”) and “SEGAI-ULL”. S.P-Y is funded by “Fundación Doctor Manuel Morales” (La Palma, Spain) and “Contrato Predoctoral Ministerio-ULL Formación de Doctores” (2019 Program) (“Ministerio de Ciencia, Innovación y Universidades”, Spain). R.C.-R. is funded by RD16/0025/0011 and ProID2020010093 (“Agencia Canaria de Investigación, Innovación y Sociedad de la Información” and European Social Fund). J.G.-L. is funded by the “Juan de la Cierva de Incorporación” Spanish Program (IJC2019-038902-I) (“Ayudas Juan de la Cierva de incorporación; Agencia Estatal de Investigación. Ministerio de Ciencia e Innovación”). | es_ES |
| dc.format.number | 11 | es_ES |
| dc.format.page | 6180 | es_ES |
| dc.format.volume | 23 | es_ES |
| dc.identifier.citation | Int J Mol Sci. 2022 May 31;23(11):6180. | es_ES |
| dc.identifier.doi | 10.3390/ijms23116180 | es_ES |
| dc.identifier.e-issn | 1422-0067 | es_ES |
| dc.identifier.journal | International journal of molecular sciences | es_ES |
| dc.identifier.pubmedID | 35682862 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/15178 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD12%2F0017%2F0002/ES/SIDA/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RD12/0017/0034 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RD12/0017/0028 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0011/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0041/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RDCIII16/0002/0005 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01318/ES/IDENTIFICACION DE BIOMARCADORES DE UTILIDAD DIAGNOSTICA EN PACIENTES ALERGICOS A LTP DE FENOTIPO GRAVE. MECANISMOS IMPLICADOS EN LA EFICACIA DE LA INMUNOTERAPIA CON LTP./ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00093/ES/IMPACTO DELA FUNCION Y LA ANTIGENICIDAD DE LA GLUCOPROTEINA DE LA ENVUELTA DE VIH-1 EN EL CONTROL DE ELITE DE LA REPLICACION VIRAL/ | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI17/01318 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI20/00093 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI13/02269 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/CE/RTI2018-093747-B-100 | es_ES |
| dc.relation.publisherversion | https://doi.org/10.3390/ijms23116180 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution 4.0 Internacional | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | TARDBP/TDP-43 | es_ES |
| dc.subject | HDAC6 | es_ES |
| dc.subject | Pore fusion formation | es_ES |
| dc.subject | Cell-permissivity | es_ES |
| dc.subject | HIV-1 infection | es_ES |
| dc.subject.mesh | HIV Infections | es_ES |
| dc.subject.mesh | HIV-1 | es_ES |
| dc.subject.mesh | DNA-Binding Proteins | es_ES |
| dc.subject.mesh | Histone Deacetylase 6 | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | T-Lymphocytes | es_ES |
| dc.title | Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6 | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 7e48a263-54c3-4de0-81e7-f7446c918f2d | |
| relation.isAuthorOfPublication | cca7e901-0913-4b71-8c9d-ee7dd20b6458 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7e48a263-54c3-4de0-81e7-f7446c918f2d |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- TransactiveResponseDNA-BindingProtein_2022.pdf
- Size:
- 5.31 MB
- Format:
- Adobe Portable Document Format
- Description:


